Preclinical Assessment of Antiviral Combination Therapy in a Genetically Humanized Mouse Model for Hepatitis Delta Virus Infection

Science Translational Medicine - United States
doi 10.1126/scitranslmed.aap9328
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

A Novel Immunogenic Mouse Model of Melanoma for the Preclinical Assessment of Combination Targeted and Immune-Based Therapy

Scientific Reports
Multidisciplinary
2019English

Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity

Clinical Cancer Research
Cancer ResearchOncology
2011English

Humanized Antibodies for Antiviral Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model

Frontiers in Immunology
AllergyImmunology
2017English

Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2014English

Completion of the Entire Hepatitis C Virus Life Cycle in Genetically Humanized Mice

Nature
Multidisciplinary
2013English

In Vivo Antiviral Efficacy of Prenylation Inhibitors Against Hepatitis Delta Virus

Journal of Clinical Investigation
Medicine
2003English

A Methodology Concern of the Meta-Analysis of Antiviral Therapy for Chronic Hepatitis B Virus Infection in Adults

Hepatology
MedicineHepatology
2016English

In Vivo Antiviral Efficacy of Prenylation Inhibitors Against Hepatitis Delta Virus

Journal of Clinical Investigation
Medicine
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy